DNA

Simpli5 Celebrates 15 Years of Revolutionizing Team Performance Through Energy Dynamics

AUSTIN, Texas, June 11, 2025 /PRNewswire/ -- Simpli5, the innovative platform powered by the 5 Dynamics methodology, proudly celebrates 15…

6 months ago

vTv Therapeutics to Participate in the H.C. Wainwright “HCW@Home” Series

HIGH POINT, N.C., June 11, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on…

6 months ago

Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing

Facility provides additional funding for next steps of the Company’s growth, including the expected launch of bezuclastinib in 2026 On…

6 months ago

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress

– 7 of 8 myositis patients achieved clinically meaningful TIS responses after discontinuation of all immunomodulators, while off or actively…

6 months ago

Basecamp Research Announces Breakthrough Discovery of Over One Million New Species, Yielding Enormous New Database Purpose-Built for Generative Foundation Models in Biology

Head to Head Comparison Size and Diversity: Protein Model Training Datasets 10X Tree of Life Expanding Our View of The…

6 months ago

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

SAN DIEGO, June 10, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), aligned with its commitments to advance the power of…

7 months ago

Nexus IT Secures $60M Investment to Accelerate Founder-Led, Values-Driven MSP/MSSP Expansion

New investment from Metropolitan Partners Group positions Nexus IT to lead a values-aligned M&A model reshaping the managed services landscape. SALT LAKE CITY, June 10, 2025 /PRNewswire/ -- Nexus IT, a nationally recognized Managed Services…

7 months ago

Ascend Completes GMP Certification for Quality Control Testing in Munich Facility

- Enables streamlined stability testing and release of higher quality AAV-based gene therapy products. - Provides much needed European capacity…

7 months ago

Roji Health Intelligence Achieves HITRUST e1 Certification Demonstrating Foundational Cybersecurity

HITRUST e1 Certification validates Roji Health Intelligence is committed to foundational cybersecurity controls and information risk managementCHICAGO, June 10, 2025…

7 months ago

Vivex® Biologics, Inc. Appoints Industry Veteran Jon E. Block, Ph.D., as Chief Clinical Officer

Dr. Jon Block to Lead Vivex’s Completion of its Ascend and Restore Randomized Clinical Trials for VIA Disc® NP, Vivex’s…

7 months ago